Skip to main content
Clinical Trials/NCT06485895
NCT06485895RecruitingNot Applicable

Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis

Assistance Publique Hopitaux De Marseille1 site in 1 country500 target enrollmentStarted: July 30, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
500
Locations
1
Primary Endpoint
specificity of TB-IGRA 2nd generation test

Study Overview

Brief Summary

Methodology This is a single-center study carried out as part of routine patient care.

The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.

Detailed Description

It is planned to include 500 patients. An enrolment of 455 subjects will enable us to demonstrate sensitivity-specificity levels of 92% for a 95% confidence interval and a 0.05 degree of precision. To take account of non-analyzable samples or tests, the investigator will include 500 subjects

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Individual at least 18 years of age
  • •Patient presenting for treatment of tuberculosis disease
  • •Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test.
  • •Informed patient who has not expressed opposition to participating in the study.
  • •French-speaking patient with unambiguous understanding of oral and written instructions.

Exclusion Criteria

  • •Persons in a period of exclusion from another study
  • •Pregnant, parturient or breast-feeding women;
  • •Person deprived of liberty by judicial or administrative decision

Arms & Interventions

TUBERCULOSIS (LATENTE OR ACTIVE) ARM

Experimental

Intervention: test IGRA (Diagnostic Test)

TUBERCULOSIS (LATENTE OR ACTIVE) ARM

Experimental

Intervention: TEST QUATIFERON TB Gold Plus (Diagnostic Test)

Outcomes

Primary Outcomes

specificity of TB-IGRA 2nd generation test

Time Frame: 24 MONTHS

sensitivity of TB-IGRA 2nd generation test

Time Frame: 24 MONTHS

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials